These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 25243167

  • 21. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells.
    Jia SJ, Jiang DJ, Hu CP, Zhang XH, Deng HW, Li YJ.
    Vascul Pharmacol; 2006 Mar; 44(3):143-8. PubMed ID: 16309971
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells.
    Sakurada M, Shichiri M, Imamura M, Azuma H, Hirata Y.
    Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664
    [Abstract] [Full Text] [Related]

  • 24. GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans.
    Chobanyan K, Thum T, Suchy MT, Zhu B, Mitschke A, Gutzki FM, Beckmann B, Stichtenoth DO, Tsikas D.
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct 15; 858(1-2):32-41. PubMed ID: 17825631
    [Abstract] [Full Text] [Related]

  • 25. Anti-hypertensive effects of shichimotsukokato in 5/6 nephrectomized Wistar rats mediated by the DDAH-ADMA-NO pathway.
    Bai F, Makino T, Ono T, Mizukami H.
    J Nat Med; 2012 Oct 15; 66(4):583-90. PubMed ID: 22350214
    [Abstract] [Full Text] [Related]

  • 26. PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy.
    Chen Y, Xu X, Sheng M, Zhang X, Gu Q, Zheng Z.
    Exp Eye Res; 2009 Dec 15; 89(6):1028-34. PubMed ID: 19748504
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Melatonin blocks oxidative stress-induced increased asymmetric dimethylarginine.
    Tain YL, Kao YH, Hsieh CS, Chen CC, Sheen JM, Lin IC, Huang LT.
    Free Radic Biol Med; 2010 Sep 15; 49(6):1088-98. PubMed ID: 20600827
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats.
    Wakino S, Hayashi K, Tatematsu S, Hasegawa K, Takamatsu I, Kanda T, Homma K, Yoshioka K, Sugano N, Saruta T.
    Hypertens Res; 2005 Mar 15; 28(3):255-62. PubMed ID: 16097370
    [Abstract] [Full Text] [Related]

  • 35. Isoform-specific regulation by N(G),N(G)-dimethylarginine dimethylaminohydrolase of rat serum asymmetric dimethylarginine and vascular endothelium-derived relaxing factor/NO.
    Wang D, Gill PS, Chabrashvili T, Onozato ML, Raggio J, Mendonca M, Dennehy K, Li M, Modlinger P, Leiper J, Vallance P, Adler O, Leone A, Tojo A, Welch WJ, Wilcox CS.
    Circ Res; 2007 Sep 14; 101(6):627-35. PubMed ID: 17673667
    [Abstract] [Full Text] [Related]

  • 36. DDAH-1, via regulation of ADMA levels, protects against ischemia-induced blood-brain barrier leakage.
    Zhao Y, Ma X, Zhou Y, Xie J, Liu X, Zhao Y.
    Lab Invest; 2021 Jul 14; 101(7):808-823. PubMed ID: 33574439
    [Abstract] [Full Text] [Related]

  • 37. Liver plays a central role in asymmetric dimethylarginine-mediated organ injury.
    Ferrigno A, Di Pasqua LG, Berardo C, Richelmi P, Vairetti M.
    World J Gastroenterol; 2015 May 07; 21(17):5131-7. PubMed ID: 25954086
    [Abstract] [Full Text] [Related]

  • 38. Mechanisms of nitric oxide synthase uncoupling in endotoxin-induced acute lung injury: role of asymmetric dimethylarginine.
    Sharma S, Smith A, Kumar S, Aggarwal S, Rehmani I, Snead C, Harmon C, Fineman J, Fulton D, Catravas JD, Black SM.
    Vascul Pharmacol; 2010 May 07; 52(5-6):182-90. PubMed ID: 19962451
    [Abstract] [Full Text] [Related]

  • 39. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension.
    Millatt LJ, Whitley GS, Li D, Leiper JM, Siragy HM, Carey RM, Johns RA.
    Circulation; 2003 Sep 23; 108(12):1493-8. PubMed ID: 12952847
    [Abstract] [Full Text] [Related]

  • 40. Effect of ischemia-reperfusion on renal expression and activity of N(G)-N(G)-dimethylarginine dimethylaminohydrolases.
    Li Volti G, Sorrenti V, Acquaviva R, Murabito P, Gullo A, Barcellona ML, Galvano F, Rodella L, Rezzani R, Vanella L, Tringali G, Caruso M, Gazzolo D, Di Giacomo C.
    Anesthesiology; 2008 Dec 23; 109(6):1054-62. PubMed ID: 19034102
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.